Focus on alcoholic liver disease: From nosography to treatment

World Journal of Gastroenterology

Volumn 20, Issue 25, 2014, Pages 8040-8047

  Streba, Letiţia Adela Maria ^a   Vere, Cristin Constantin ^a   Streba, Costin Teodor ^a   Ciurea, Marius Eugen ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

Author keywords

Alcoholic liver disease; Diagnosis; Epidemiology; Risk factors; Treatment

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA CHEMOKINE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARBOHYDRATE DEFICIENT TRANSFERRIN; COMPLEMENT; CORTICOSTEROID; ETANERCEPT; FOLIC ACID; GAMMA GLUTAMYLTRANSFERASE; INFLIXIMAB; INTERLEUKIN 22; PENTOXIFYLLINE; PROBIOTIC AGENT; PYRIDOXINE; RETINOL; S ADENOSYLMETHIONINE; THIAMINE; CREATININE;

ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ALCOHOLIC FATTY LIVER; ARTICLE; BINGE DRINKING; CLINICAL TRIAL (TOPIC); COGNITIVE THERAPY; DEATH; DIET THERAPY; DRINKING BEHAVIOR; FATTY LIVER; HEALTH CARE COST; HEPATIC ENCEPHALOPATHY; HEPATOMEGALY; HUMAN; LIFESTYLE MODIFICATION; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; MEAN CORPUSCULAR VOLUME; MEDICAL PROCEDURES; META ANALYSIS (TOPIC); NEUTROPHILIA; NOSOGRAPHY; PROGNOSIS; RISK FACTOR; SCORING SYSTEM; THROMBOCYTOPENIA; VOCATIONAL REHABILITATION; COMORBIDITY; DISEASE COURSE; FEEDING BEHAVIOR; GENETIC PREDISPOSITION; LIFESTYLE; LIVER DISEASES, ALCOHOLIC; MEDICAL GEOGRAPHY; MORTALITY; PREDICTIVE VALUE; RISK ASSESSMENT; ALCOHOLIC BEVERAGE; CLINICAL FEATURE; HEALTH CARE SURVEY; HOSPITALIZATION; INFORMATION PROCESSING; MORBIDITY; PATHOPHYSIOLOGY; PREVALENCE; PROTHROMBIN TIME; RADIOGRAPHY; REVIEW; STEATOSIS; TREATMENT PLANNING;

COMORBIDITY; DISEASE PROGRESSION; FOOD HABITS; GENETIC PREDISPOSITION TO DISEASE; GEOGRAPHY, MEDICAL; HUMANS; LIFE STYLE; LIVER DISEASES, ALCOHOLIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 84904018362     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i25.8040     Document Type: Article

References (88)

1. Pessione F, Ramond MJ, Peters L, Pham BN, Batel P, Rueff B, Valla DC. Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence. Liver Int 2003; 23: 45-53 [PMID: 12640727 DOI: 10.1034/j.1600-0676.2003.01804.x]
2. Paula H, Asrani SK, Boetticher NC, Pedersen R, Shah VH, Kim WR. Alcoholic liver disease-related mortality in the United States: 1980-2003. Am J Gastroenterol 2010; 105: 1782-1787 [PMID: 20179691 DOI: 10.1038/ajg.2010.46]
3. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcoholuse disorders. Lancet 2009; 373: 2223-2233 [PMID: 19560604 DOI: 10.1016/S0140-6736(09)60746-7]
4. O'Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Am J Gastroenterol 2010; 105: 14-32; quiz 33 [PMID: 19904248 DOI: 10.1038/ajg.2009.593]
5. European Association for the Study of Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol 2012; 57: 399-420 [PMID: 22633836]
6. Shah VH. Alcoholic liver disease: the buzz may be gone, but the hangover remains. Hepatology 2010; 51: 1483-1484 [PMID: 20432249 DOI: 10.1002/hep.23686]
7. Stickel F, Osterreicher CH. The role of genetic polymorphisms in alcoholic liver disease. Alcohol Alcohol 2006; 41: 209-224 [PMID: 16492723 DOI: 10.1093/alcalc/agl011]
8. Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011; 141: 1572-1585 [PMID: 21920463 DOI: 10.1053/j.gastro.2011.09.002]
9. Zakhari S, Li TK. Determinants of alcohol use and abuse: Impact of quantity and frequency patterns on liver disease. Hepatology 2007; 46: 2032-2039 [PMID: 18046720 DOI: 10.1002/hep.22010]
10. Ceccanti M, Attili A, Balducci G, Attilia F, Giacomelli S, Rotondo C, Sasso GF, Xirouchakis E, Attilia ML. Acute alcoholic hepatitis. J Clin Gastroenterol 2006; 40: 833-841 [PMID: 17016141 DOI: 10.1097/01.mcg.0000225570.04773.5d]
11. Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 2013; 58: 593-608 [PMID: 23419824 DOI: 10.1016/j.jhep.2012.12.005]
12. Singal AK, Anand BS. Recent trends in the epidemiology of alcoholic liver disease. Clinical Liver Disease 2013; 2: 53-56 [DOI: 10.1002/cld.168]
13. Basra S, Anand BS. Definition, epidemiology and magnitude of alcoholic hepatitis. World J Hepatol 2011; 3: 108-113 [PMID: 21731902 DOI: 10.4254/wjh.v3.i5.108]
14. World Health Organization. Status report on alcohol and health in 35 European countries 2013. Available from: URL: http:// www.euro.who.int/__data/assets/pdf_file/0017/190430/Status-Report-on-Alcohol-and-Health-in-35-European-Countries. pdf
15. Sandahl TD, Jepsen P, Thomsen KL, Vilstrup H. Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: a nationwide population based cohort study. J Hepatol 2011; 54: 760-764 [PMID: 21126790 DOI: 10.1016/j.jhep.2010.07.016]
16. Jepsen P, Vilstrup H, Sørensen HT. Alcoholic cirrhosis in Denmark-population-based incidence, prevalence, and hospitalization rates between 1988 and 2005: a descriptive cohort study. BMC Gastroenterol 2008; 8: 3 [PMID: 18261240 DOI: 10.1186/1471-230X-8-3]
17. Michitaka K, Nishiguchi S, Aoyagi Y, Hiasa Y, Tokumoto Y, Onji M. Etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol 2010; 45: 86-94 [PMID: 19789837 DOI: 10.1007/s00535-009-0128-5]
18. Wiegand J, Berg T. The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis. Dtsch Arztebl Int 2013; 110: 85-91 [PMID: 23451000 DOI: 10.3238/ arztebl.2013.0085]
19. Dhanda AD, Lee RW, Collins PL, McCune CA. Molecular targets in the treatment of alcoholic hepatitis. World J Gastroenterol 2012; 18: 5504-5513 [PMID: 23112542 DOI: 10.3748/ wjg.v18.i39.5504]
20. Kochanek KD, Xu JQ, Murphy SL, Miniño AM, Kung HC. Deaths: Final Data for 2009. Natl Vital Stat Rep 2011; 59: 1-51
21. Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol 2013; 59: 160-168 [PMID: 23511777 DOI: 10.1016/j.jhep.2013.03.007]
22. Kaplan W. Alcohol Use Disorders: Alcoholic Liver Diseases and Alcohol Dependency. Opportunities to Address Pharmaceutical Gaps. In: Kaplan W, Laing R, editors. Priority Medicines for Europe and the World. Geneva: World Health Organization, 2004
23. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004; 127: S87-S96 [PMID: 15508108 DOI: 10.1053/j.gastro.2004.09.020]
24. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004; 127: S35-S50 [PMID: 15508101 DOI: 10.1053/ j.gastro.2004.09.014]
25. Jepsen P, Ott P, Andersen PK, Sørensen HT, Vilstrup H. Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study. Ann Intern Med 2012; 156: 841-847, W295 [PMID: 22711076 DOI: 10.7326/000 3-4819-156-12-201206190-00004]
26. Frazier TH, Stocker AM, Kershner NA, Marsano LS, Mc-Clain CJ. Treatment of alcoholic liver disease. Therap Adv Gastroenterol 2011; 4: 63-81 [PMID: 21317995 DOI: 10.1177/17 56283X10378925]
27. McClain CJ, Song Z, Barve SS, Hill DB, Deaciuc I. Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2004; 287: G497-G502 [PMID: 15331349 DOI: 10.1152/ajpgi.00171.2004]
28. Zhu H, Jia Z, Misra H, Li YR. Oxidative stress and redox signaling mechanisms of alcoholic liver disease: updated experimental and clinical evidence. J Dig Dis 2012; 13: 133-142 [PMID: 22356308 DOI: 10.1111/j.1751-2980.2011.00569.x]
29. Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med 2009; 360: 2758-2769 [PMID: 19553649 DOI: 10.1056/NEJMra0805786]
30. Savolainen VT, Liesto K, Männikkö A, Penttilä A, Karhunen PJ. Alcohol consumption and alcoholic liver disease: evidence of a threshold level of effects of ethanol. Alcohol Clin Exp Res 1993; 17: 1112-1117 [PMID: 8279675 DOI: 10.1111/ j.1530-0277.1993.tb05673.x]
31. Arteel G, Marsano L, Mendez C, Bentley F, McClain CJ. Advances in alcoholic liver disease. Best Pract Res Clin Gastroenterol 2003; 17: 625-647 [PMID: 12828959 DOI: 10.1016/ S1521-6918(03)00053-2]
32. Corrao G, Bagnardi V, Zambon A, Torchio P. Meta-analysis of alcohol intake in relation to risk of liver cirrhosis. Alcohol Alcohol 1998; 33: 381-392 [PMID: 9719397 DOI: 10.1093/oxfordjournals. alcalc.a008408]
33. McCullough AJ, O'Connor JF. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998; 93: 2022-2036 [PMID: 9820369 DOI: 10.1111/j.1572-0241.1998.00587.x]
34. Mueller S, Millonig G, Seitz HK. Alcoholic liver disease and hepatitis C: a frequently underestimated combination. World J Gastroenterol 2009; 15: 3462-3471 [PMID: 19630099 DOI: 10.3748/wjg.15.3462]
35. Becker U, Grønbaek M, Johansen D, Sørensen TI. Lower risk for alcohol-induced cirrhosis in wine drinkers. Hepatology 2002; 35: 868-875 [PMID: 11915033 DOI: 10.1053/ jhep.2002.32101]
36. Pelletier S, Vaucher E, Aider R, Martin S, Perney P, Balmès JL, Nalpas B. Wine consumption is not associated with a decreased risk of alcoholic cirrhosis in heavy drinkers. Alcohol Alcohol 2002; 37: 618-621 [PMID: 12414558 DOI: 10.1093/alcalc/ 37.6.618]
37. Hatton J, Burton A, Nash H, Munn E, Burgoyne L, Sheron N. Drinking patterns, dependency and life-time drinking history in alcohol-related liver disease. Addiction 2009; 104: 587-592 [PMID: 19215600 DOI: 10.1111/j.1360-0443.2008.02493.x]
38. Wechsler H, Austin SB. Binge drinking: the five/four measure. J Stud Alcohol 1998; 59: 122-124 [PMID: 9498324]
39. Tolstrup JS, Jensen MK, Tjønneland A, Overvad K, Grønbaek M. Drinking pattern and mortality in middle-aged men and women. Addiction 2004; 99: 323-330 [PMID: 14982545 DOI: 10.1111/j.1360-0443.2003.00667.x]
40. Nanji AA, Su GL, Laposata M, French SW. Pathogenesis of alcoholic liver disease--recent advances. Alcohol Clin Exp Res 2002; 26: 731-736 [PMID: 12045483]
41. Gramenzi A, Caputo F, Biselli M, Kuria F, Loggi E, Andreone P, Bernardi M. Review article: alcoholic liver disease--pathophysiological aspects and risk factors. Aliment Pharmacol Ther 2006; 24: 1151-1161 [PMID: 17014574 DOI: 10.1111/ j.1365-2036.2006.03110.x]
42. Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 1990; 322: 95-99 [PMID: 2248624 DOI: 10.1056/NEJM199001113220205]
43. Baraona E, Abittan CS, Dohmen K, Moretti M, Pozzato G, Chayes ZW, Schaefer C, Lieber CS. Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res 2001; 25: 502-507 [PMID: 11329488 DOI: 10.1111/j.1530-0277.2001. tb02242.x]
44. Moreno A, Parés A, Ortiz J, Enríquez J, Parés X. Alcohol dehydrogenase from human stomach: variability in normal mucosa and effect of age, gender, ADH3 phenotype and gastric region. Alcohol Alcohol 1994; 29: 663-671 [PMID: 7695781]
45. Yin SJ, Liao CS, Wu CW, Li TT, Chen LL, Lai CL, Tsao TY. Human stomach alcohol and aldehyde dehydrogenases: comparison of expression pattern and activities in alimentary tract. Gastroenterology 1997; 112: 766-775 [PMID: 9041238 DOI: 10.1053/gast.1997.v112.pm9041238]
46. Lai CL, Chao YC, Chen YC, Liao CS, Chen MC, Liu YC, Yin SJ. No sex and age influence on the expression pattern and activities of human gastric alcohol and aldehyde dehydrogenases. Alcohol Clin Exp Res 2000; 24: 1625-1632 [PMID: 11104109 DOI: 10.1111/j.1530-0277.2000.tb01963.x]
47. Ely M, Hardy R, Longford NT, Wadsworth ME. Gender differences in the relationship between alcohol consumption and drink problems are largely accounted for by body water. Alcohol Alcohol 1999; 34: 894-902 [PMID: 10659726 DOI: 10.1093/alcalc/34.6.894]
48. Eagon PK. Alcoholic liver injury: influence of gender and hormones. World J Gastroenterol 2010; 16: 1377-1384 [PMID: 20238405 DOI: 10.3748/wjg.v16.i11.1377]
49. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. Hepatology 1997; 25: 108-111 [PMID: 8985274 DOI: 10.1002/ hep.510250120]
50. Lu XL, Luo JY, Tao M, Gen Y, Zhao P, Zhao HL, Zhang XD, Dong N. Risk factors for alcoholic liver disease in China. World J Gastroenterol 2004; 10: 2423-2426 [PMID: 15285035]
51. Leevy CM, Moroianu SA. Nutritional aspects of alcoholic liver disease. Clin Liver Dis 2005; 9: 67-81 [PMID: 15763230 DOI: 10.1016/j.cld.2004.11.003]
52. Monto A, Patel K, Bostrom A, Pianko S, Pockros P, McHutchison JG, Wright TL. Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology 2004; 39: 826-834 [PMID: 14999703 DOI: 10.1002/hep.20127]
53. Stinson FS, Grant BF, Dufour MC. The critical dimension of ethnicity in liver cirrhosis mortality statistics. Alcohol Clin Exp Res 2001; 25: 1181-1187 [PMID: 11505049 DOI: 10.1111/ j.1530-0277.2001.tb02333.x]
54. Järveläinen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology 2001; 33: 1148-1153 [PMID: 11343243 DOI: 10.1053/jhep.2001.24236]
55. Whitfield JB. Alcohol dehydrogenase and alcohol dependence: variation in genotype-associated risk between populations. Am J Hum Genet 2002; 71: 1247-1250; author reply 1250-1251 [PMID: 12452180 DOI: 10.1086/344287]
56. Zintzaras E, Stefanidis I, Santos M, Vidal F. Do alcoholmetabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease? Hepatology 2006; 43: 352-361 [PMID: 16440362 DOI: 10.1002/hep.21023]
57. Stickel F, Buch S, Lau K, Meyer zu Schwabedissen H, Berg T, Ridinger M, Rietschel M, Schafmayer C, Braun F, Hinrichsen H, Günther R, Arlt A, Seeger M, Müller S, Seitz HK, Soyka M, Lerch M, Lammert F, Sarrazin C, Kubitz R, Häussinger D, Hellerbrand C, Bröring D, Schreiber S, Kiefer F, Spanagel R, Mann K, Datz C, Krawczak M, Wodarz N, Völzke H, Hampe J. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians. Hepatology 2011; 53: 86-95 [PMID: 21254164 DOI: 10.1002/hep.24017]
58. Marsano LS, Mendez C, Hill D, Barve S, McClain CJ. Diagnosis and treatment of alcoholic liver disease and its complications. Alcohol Res Health 2003; 27: 247-256 [PMID: 15535453]
59. Nalpas B, Hispard E, Thépot V, Pot S, Dally S, Berthelot P. A comparative study between carbohydrate-deficient transferrin and gamma-glutamyltransferase for the diagnosis of excessive drinking in a liver unit. J Hepatol 1997; 27: 1003-1008 [PMID: 9453425 DOI: 10.1016/S0168-8278(97)80143-2]
60. Madhubala V, Subhashree AR, Shanthi B. Serum carbohydrate deficient transferrin as a sensitive marker in diagnosing alcohol abuse: a case-control study. J Clin Diagn Res 2013; 7: 197-200 [PMID: 23542570 DOI: 10.7860/JCDR/2013/5137.2726]
61. Niemelä O. Biomarkers in alcoholism. Clin Chim Acta 2007; 377: 39-49 [PMID: 17045579 DOI: 10.1016/j.cca.2006.08.035]
62. Allen JP, Litten RZ, Strid N, Sillanaukee P. The role of biomarkers in alcoholism medication trials. Alcohol Clin Exp Res 2001; 25: 1119-1125 [PMID: 11505042 DOI: 10.1111/ j.1530-0277.2001.tb02325.x]
63. LEEVY CM. Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature. Medicine (Baltimore) 1962; 41: 249-276 [PMID: 14463641 DOI: 10.1097/000 05792-196209000-00003]
64. Stickel F, Seitz HK. Alcoholic steatohepatitis. Best Pract Res Clin Gastroenterol 2010; 24: 683-693 [PMID: 20955970 DOI: 10.1016/j.bpg.2010.07.003]
65. Maddrey WC, Boitnott JK, Bedine MS, Weber FL, Mezey E, White RI. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75: 193-199 [PMID: 352788]
66. Carithers RL, Herlong HF, Diehl AM, Shaw EW, Combes B, Fallon HJ, Maddrey WC. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med 1989; 110: 685-690 [PMID: 2648927 DOI: 10.7326/0003-4819-110-9-685]
67. Kulkarni K, Tran T, Medrano M, Yoffe B, Goodgame R. The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis. J Clin Gastroenterol 2004; 38: 453-459 [PMID: 15100527 DOI: 10.1097/00004836-200405000-00012]
68. Forrest EH, Evans CD, Stewart S, Phillips M, Oo YH, McAvoy NC, Fisher NC, Singhal S, Brind A, Haydon G, O'Grady J, Day CP, Hayes PC, Murray LS, Morris AJ. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut 2005; 54: 1174-1179 [PMID: 16009691 DOI: 10.1136/ gut.2004.050781]
69. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871 [PMID: 10733541 DOI: 10.1053/ he.2000.5852]
70. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470 [PMID: 11172350 DOI: 10.1053/jhep.2001.22172]
71. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006; 130: 1652-1660 [PMID: 16697729 DOI: 10.1053/ j.gastro.2006.02.010]
72. Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, Dharancy S, Texier F, Hollebecque A, Serfaty L, Boleslawski E, Deltenre P, Canva V, Pruvot FR, Mathurin P. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007; 45: 1348-1354 [PMID: 17518367 DOI: 10.1002/hep.21607]
73. Dominguez M, Rincón D, Abraldes JG, Miquel R, Colmenero J, Bellot P, García-Pagán JC, Fernández R, Moreno M, Bañares R, Arroyo V, Caballería J, Ginès P, Bataller R. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol 2008; 103: 2747-2756 [PMID: 18721242 DOI: 10.1111/j.1572-0241.2008.02104.x]
74. Forrest EH, Morris AJ, Stewart S, Phillips M, Oo YH, Fisher NC, Haydon G, O'Grady J, Day CP. The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids. Gut 2007; 56: 1743-1746 [PMID: 17627961 DOI: 10.1136/gut.2006.099226]
75. Mathurin P, O'Grady J, Carithers RL, Phillips M, Louvet A, Mendenhall CL, Ramond MJ, Naveau S, Maddrey WC, Morgan TR. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut 2011; 60: 255-260 [PMID: 20940288 DOI: 10.1136/gut.2010.224097]
76. Sandahl TD, Jepsen P, Ott P, Vilstrup H. Validation of prognostic scores for clinical use in patients with alcoholic hepatitis. Scand J Gastroenterol 2011; 46: 1127-1132 [PMID: 21591871 DOI: 10.3109/00365521.2011.587200]
77. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371: 838-851 [PMID: 18328931 DOI: 10.1016/S0140-6736(08)60383-9]
78. Heidelbaugh JJ, Bruderly M. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. Am Fam Physician 2006; 74: 756-762 [PMID: 16970019]
79. Parés A, Caballería J, Bruguera M, Torres M, Rodés J. Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. J Hepatol 1986; 2: 33-42 [PMID: 3950362 DOI: 10.1016/S0168-8278(86)80006-X]
80. Bien TH, Miller WR, Tonigan JS. Brief interventions for alcohol problems: a review. Addiction 1993; 88: 315-335 [PMID: 8461850 DOI: 10.1111/j.1360-0443.1993.tb00820.x]
81. Mezey E, Potter JJ, Rennie-Tankersley L, Caballeria J, Pares A. A randomized placebo controlled trial of vitamin E for alcoholic hepatitis. J Hepatol 2004; 40: 40-46 [PMID: 14672612 DOI: 10.1016/S0168-8278(03)00476-8]
82. Parés A, Planas R, Torres M, Caballería J, Viver JM, Acero D, Panés J, Rigau J, Santos J, Rodés J. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol 1998; 28: 615-621 [PMID: 9566830 DOI: 10.1016/ S0168-8278(98)80285-7]
83. Rambaldi A, Saconato HH, Christensen E, Thorlund K, Wetterslev J, Gluud C. Systematic review: glucocorticosteroids for alcoholic hepatitis--a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther 2008; 27: 1167-1178 [PMID: 18363896 DOI: 10.1111/ j.1365-2036.2008.03685.x]
84. De BK, Gangopadhyay S, Dutta D, Baksi SD, Pani A, Ghosh P. Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial. World J Gastroenterol 2009; 15: 1613-1619 [PMID: 19340904 DOI: 10.3748/ wjg.15.1613]
85. Mathurin P, Louvet A, Duhamel A, Nahon P, Carbonell N, Boursier J, Anty R, Diaz E, Thabut D, Moirand R, Lebrec D, Moreno C, Talbodec N, Paupard T, Naveau S, Silvain C, Pageaux GP, Sobesky R, Canva-Delcambre V, Dharancy S, Salleron J, Dao T. Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial. JAMA 2013; 310: 1033-1041 [PMID: 24026598 DOI: 10.1001/jama.2013.276300]
86. Anstee QM, Day CP. S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility. J Hepatol 2012; 57: 1097-1109 [PMID: 22659519 DOI: 10.1016/j.jhep.2012.04.041]
87. Kirpich IA, McClain CJ. Probiotics in the treatment of the liver diseases. J Am Coll Nutr 2012; 31: 14-23 [PMID: 22661622 DOI: 10.1080/07315724.2012.10720004]
88. Colmenero J, Bataller R, Sancho-Bru P, Bellot P, Miquel R, Moreno M, Jares P, Bosch J, Arroyo V, Caballería J, Ginès P. Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. Gastroenterology 2007; 132: 687-697 [PMID: 17258719 DOI: 10.1053/ j.gastro.2006.12.036]